YTHDF1 and hepatocellular carcinoma: For example, Su et al.demonstrated in the HCC model that YTHDF1 silencing combined with EGFR inhibition synergically suppressed the malignancies of HCC cells, suggesting that YTHDF1 inhibition may be of great value in cancer treatment [440].